Category: Heel Pharmacological Index

Paratyphoidinum-B-Injeel and forte

see Salmonella paratyphi B-Injeel.

Hepar suis-Injeel and forte
(liver)

Damaged liver and deficient hepatic detoxication, chronic eczema, neurodermatitis, psoriasis, erythematosus, porphyria; also for dermatomycosis, pemphigus and kraurosis vulvae, male sterility, radiation sickness, hypoglycemia, anorexia nervosa; frequently indicated as intermediate remedy in cellular phases. To stimulate the detoxicating hepatic function; also indicated for arthrosis deformans and periarthritis humeroscapularis.

Saccharum-Injeel
D 10, D 30, D 200 0.367 ml each.

Dental caries, weakness of the connective tissue; as adjuvant for (trichomonas) leucorrhoea.

Quebracho-Injeel
D 10, D 30, D 200 0.367 ml each.
Quebracho-Injeel forte
D 4, D 10, D 30, D 200 0.275 ml each.

Bronchitis, smoker’s catarrh, bronchial asthma, emphysema.

Aesculus-Injeel
D 12, D 30, D 200 0.367 ml each.
Aesculus-Injeel forte
D 3, D 6, D 12, D 30, D 200 0.220 ml each.

Venous stasis, haemorrhoids, varicose veins, paresthesis, lumbosacral pain.

Fucus vesiculosus-Injeel
D 12, D 30, D 200 0.367 ml each.
Fucus vesiculosus-Injeel forte
D 4, D 12, D 30, D 200 0.275 ml each.

Scrofulous glandular swelling; goitre, adiposis, arteriosclerosis.

Contraindications

In case of thyroid disorders, this preparation may not be administered without prior approval from a physician.

Side effects

This medication can aggravate thyroid hyperfunction.

Carcinoma hepatis-Injeel
D 10, D 30, D 200 0.367 ml each.
Carcinoma hepatis-Injeel forte
D 6, D 10, D 30, D 200 0.275 ml each.

For auxiliary/additional therapy in primary tumors of the liver as well as in hepatic metastases.

Bufo-Injeel
D 15, D 30, D 200 0.367 ml each.
Bufo-Injeel forte
D 8, D 15, D 30, D 200 0.275 ml each.

Convulsions, vesicular eczema.

Funiculus umbilicalis suis-Injeel and forte
[Wharton’s jelly (umbilical cord)]

Remedy for affections of the connective tissue indicated in almost all chronic diseases. Damaged connective tissue, adhesions, osteochondrosis, premature aging, formation of wrinkles, adynamia, arteriosclerosis, cervical syndrome, coxitis, diverticulitis, chronic colitis, lupus erythematosus, collagen diseases, scleroderma, fibromas, vascular disorders, geriatric Indications of all kinds, glaucoma, circulatory disorders, vegetative dystonia, radiation damage, duodenal ulcers et ventriculi, pruritus vulvae, psoriasis, sarcoma and carcinoma, auto-aggression diseases, damage through antibiotics and therapeutics, general therapeutical damage, scrofulosis, otosclerosis, multiple sclerosis, muscular atrophy, intervertebral neuralgia, neurodermatitis, oedema, marasmus, cachexia, lymphogranulomatosis, myopia, acne rosacea, decubitus, dermatitis, dystrophia adiposogenitalis, elephantiasis, emphysema, exostosis, cirrhosis of the liver, tendovaginitis, hydrocele,auxiliary remedy for myxoedema, urethral stricture, fissura ani, prolapse of the uterus, erythema exudativum multiforme et nodosum, Becterew’s disease, myositis ossificans, osteomalacia. The preparation should always be combined with suitable biotherapeutical agents and other suis-organ preparations (Hypophysis suis-Injeel, Glandula suprarenalis suis-Injeel, and in particular with Traumeel S, Engystol N, Galium-Heel, Psorinoheel, Silicea-Injeel, Hepeel and especially also with the intermediary catalysts of the citric acid cycle, for the purpose of achieving particularly powerful action also with the Composita-Heel, etc.).

Hypophysis suis-Injeel and forte
Hypophysis suis
D 6; D 200 as single potencies
(pituitary gland)

Hormonal disturbances, hypophyseal obesity, dystrophia adiposo-genitalis, ovarian manifestations of endocrine deficiency; disturbances of menstruation and ovulation; chronic arthrosis and primary chronic polyarthritis, disturbances of the functions of the connective tissue, disturbances of growth, dysmenorrhoea, lactorrhoea, neurodermatitis and other skin diseases.